The New Epidemiology of Heart Failure

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2003 Apr 15

PMID 12691633

Citations 1

Authors

Richard J Rodeheffer

Affiliations

Soon will be listed here.

Abstract

In the past 5 years there has been a significant shift in the focus of heart failure epidemiology research. In the 1960 to 1995 era, persons with overt clinical heart failure were identified by assessment of typical symptoms and signs of heart failure. Recent work has gone beyond symptoms and signs, to include objective echocardiographic measurement of ventricular function. This approach has revealed that most cases of ventricular dysfunction are asymptomatic. It has also underscored the high prevalence of diastolic ventricular dysfunction in the very elderly. Nevertheless, recent data suggest that advances in heart failure therapy may be resulting in improved survival for heart failure patients in the community. Future efforts need to be directed toward early detection of ventricular dysfunction and prevention of symptomatic heart failure.

Citing Articles

Pathobiology of cardiac dyssynchrony and resynchronization.

Kass D Heart Rhythm. 2009; 6(11):1660-5.

PMID: 19879547 PMC: 3255324. DOI: 10.1016/j.hrthm.2009.08.017.

References

Senni M, Tribouilloy C, Rodeheffer R, Jacobsen S, Evans J, Bailey K . Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med. 1999; 159(1):29-34. DOI: 10.1001/archinte.159.1.29. View

Remes J, Reunanen A, Aromaa A, Pyorala K . Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J. 1992; 13(5):588-93. DOI: 10.1093/oxfordjournals.eurheartj.a060220. View

Vasan R, Benjamin E, Levy D . Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995; 26(7):1565-74. DOI: 10.1016/0735-1097(95)00381-9. View

McDonagh T, Morrison C, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray J . Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997; 350(9081):829-33. DOI: 10.1016/S0140-6736(97)03033-X. View

Kitzman D, Gardin J, Gottdiener J, Arnold A, Boineau R, Aurigemma G . Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001; 87(4):413-9. DOI: 10.1016/s0002-9149(00)01393-x. View

McDonagh T, Robb S, Murdoch D, Morton J, Ford I, Morrison C . Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998; 351(9095):9-13. DOI: 10.1016/s0140-6736(97)03034-1. View

Schocken D, Arrieta M, Leaverton P, Ross E . Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992; 20(2):301-6. DOI: 10.1016/0735-1097(92)90094-4. View

Levy D, Garrison R, Savage D, Kannel W, CASTELLI W . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322(22):1561-6. DOI: 10.1056/NEJM199005313222203. View

Vasan R, Larson M, Benjamin E, Evans J, Levy D . Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997; 336(19):1350-5. DOI: 10.1056/NEJM199705083361903. View

10.

Massie B, Conway M . Survival of patients with congestive heart failure: past, present, and future prospects. Circulation. 1987; 75(5 Pt 2):IV11-9. View

11.

. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316(23):1429-35. DOI: 10.1056/NEJM198706043162301. View

12.

Davies M, Hobbs F, Davis R, Kenkre J, Roalfe A, Hare R . Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001; 358(9280):439-44. DOI: 10.1016/s0140-6736(01)05620-3. View

13.

Gottdiener J, Arnold A, Aurigemma G, Polak J, Tracy R, Kitzman D . Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000; 35(6):1628-37. DOI: 10.1016/s0735-1097(00)00582-9. View

14.

Senni M, Tribouilloy C, Rodeheffer R, Jacobsen S, Evans J, Bailey K . Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998; 98(21):2282-9. DOI: 10.1161/01.cir.98.21.2282. View

15.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

16.

Mosterd A, Hoes A, de Bruyne M, Deckers J, Linker D, Hofman A . Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J. 1999; 20(6):447-55. View

17.

Ho K, Anderson K, Kannel W, Grossman W, Levy D . Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993; 88(1):107-15. DOI: 10.1161/01.cir.88.1.107. View

18.

Rodeheffer R, Jacobsen S, Gersh B, Kottke T, McCann H, Bailey K . The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc. 1993; 68(12):1143-50. DOI: 10.1016/s0025-6196(12)60063-9. View

19.

Yusuf S, Pitt B, Davis C, Hood Jr W, Cohn J . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327(10):685-91. DOI: 10.1056/NEJM199209033271003. View

20.

Kenchaiah S, Evans J, Levy D, Wilson P, Benjamin E, Larson M . Obesity and the risk of heart failure. N Engl J Med. 2002; 347(5):305-13. DOI: 10.1056/NEJMoa020245. View